PBOA (Pharma & Biopharma Outsourcing Association) is a US 501(c)(6) non-profit trade association established in 2014, representing CMO/CDMO companies in the pharmaceutical and biopharmaceutical industries. Strictly speaking, it is not a SaaS or enterprise software, but rather an industry organization platform. Its core objective is to advocate for its members on regulatory, government, legislative, and general business interests.
Based on the scraped content, PBOA's core services include industry advocacy, regulatory and legislative communication, member education, advancing common industry goals, and communicating the value of CMO/CDMOs in the development and manufacturing of drugs, biologics, and vaccines. Its most practical module is the Working Groups, covering topics such as Quality Technical Group, Drug Shortages, Serialization, Opioids, Canadian Affairs, and OTC Products. Member company personnel can participate in topic discussions via conference calls, WebEx, and in-person meetings, shape the association's agenda, attend regulatory meetings and file submissions, as well as share best practices.
The website provides a "Join Today" form where users can submit a membership application and wait to be contacted, but it does not disclose membership fees, plan tiers, free trials, or payment methods. Regarding third-party integrations, it only mentions WebEx for meeting communications and Business Solutions partnerships that offer members discounts on office supplies, trade marketing, lab supplies, and manufacturing equipment, though specific partners have not yet been announced. No information was found regarding APIs, developer support, cloud deployment, or self-hosting.
PBOA explicitly displays an antitrust statement, which is a crucial compliance foundation for an association of competing businesses. The statement requires members to avoid discussing sensitive topics such as prices, fees, discounts, costs, profit margins, customers, bids, sales, and boycotts, and advises consulting legal counsel for legal issues. This reflects the association's strong emphasis on US antitrust requirements, but the text provides no information on data security, privacy protection, or information security certifications.
The main advantage is its highly focused industry positioning, making it suitable for FDA-regulated CMO/CDMO companies to obtain policy information, participate in regulatory communications, expand industry influence, and exchange views with peers on topics like quality, shortages, and serialization. The downside is its weak digital product attributes; it lacks software features, permission systems, data capabilities, and pricing transparency. The Business Solutions section also lacks specific partner information. For Chinese users, there is no mention of restrictions regarding website access, payment, or membership enrollment, so access status should be considered unknown. If enterprise collaboration software is needed, users should look for professional SaaS alternatives.
β This review is compiled from public sources and does not constitute a purchase recommendation. Verify all facts on the vendor's official site. Verify on pharma-bio.org official site.
pharma-bio.org is an United States SaaS Tools provider. TG4G tracks its product information, an overall rating of 6.0/10, and a China-accessibility score of Workable. Click "Visit Official Site" to reach pharma-bio.org directly.